The Emmes Corporation Revenue and Competitors

Location

N/A

Total Funding

Research

Industry

Employee Data

    00

The Emmes Corporation's People

NameTitleEmail/Phone
1
Director, Office the CEOReveal Email/Phone
2
President and CEOReveal Email/Phone
3
CEOReveal Email/Phone
4
Product OwnerReveal Email/Phone
5
Chief Scientific Innovation OfficerReveal Email/Phone
6
Chief Medical OfficerReveal Email/Phone
7
Chief Growth OfficerReveal Email/Phone
8
Chief Financial OfficerReveal Email/Phone
9
Chief Operating OfficerReveal Email/Phone
10
Chief Business OfficerReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$7.9M77N/AN/AN/A
#2
$557.1M39015%N/AN/A
#3
$4M49-6%N/AN/A
#4
$3.8M467%N/AN/A
#5
$2.6M35N/AN/AN/A
#6
$21M187N/AN/AN/A
#7
$2.1M29-19%N/AN/A
#8
$279.6M1958N/AN/AN/A
#9
$67.1M5265%N/AN/A
#10
$706.1M4945N/AN/AN/A
Add Company

What Is The Emmes Corporation?

Emmes offers services as a professional partner to clinicians, scientists, and program leaders. For 40 years, our staff of over 500 experienced professionals has provided the full range of Contract Research Organization expertise necessary to conduct clinical research with a firm scientific basis that is fully compliant with national and international regulatory guidelines. A collaboration with Emmes is your assurance of excellence in the important issues of public health.

keywords:N/A

N/A

Total Funding

N/A

Number of Employees

N/A

Revenue (est)

N/A

Employee Growth %

N/A

Valuation

N/A

Accelerator

The Emmes Corporation News

2022-03-22 - Emmes Acquires Casimir, Its Fourth Major Acquisition · BioBuzz

Founded in 1977, Emmes is a global, full-service Clinical Research Organization dedicated to excellence in supporting the advancement of public...

2021-08-02 - Emmes Announces New Role for the Blood and Marrow Transplant Clinical Trials Network

ROCKVILLE, Md., Aug. 2, 2021 /PRNewswire/ -- Emmes today announced that it launched a new study assessing the durability of response to COVID-19 vaccinations in patients with hematological malignancies who are undergoing cellular therapies, such as blood or marrow transplantation or CAR-T infu ...

2021-05-12 - Emmes Announces Acquisition of UK-Based Orphan Reach USA - English USA - English

ROCKVILLE, Md., May 12, 2021 /PRNewswire/ -- Emmes, a global, full-service Clinical Research Organization (CRO) dedicated to supporting the advancement of public health and biopharmaceutical innovation, today announced that it has acquired Orphan Reach, a company headquartered in the United Ki ...

2021-02-08 - Emmes Employees Contribute to New England Journal of Medicine Report on Pregnant Women with Epilepsy

ROCKVILLE, Md., Feb. 8, 2021 /PRNewswire/ -- Emmes, a global, full-service Clinical Research Organization dedicated to supporting the advancement of public health and biopharmaceutical innovation, today announced the company's involvement in a recent article published in the New England Journa ...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$43.2M0N/A$32.7M
#2
$0.1M1-97%N/A
#3
$0.1M2-90%N/A
#4
$0.1M20%N/A
#5
$0.1M20%N/A